Benchmark Reaffirms Buy Rating for CompoSecure (NASDAQ:CMPO)
CompoSecure (NASDAQ:CMPO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Benchmark in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $17.00 target price on the stock. Benchmark’s target price points to a potential upside of 23.82% from the company’s current price. CMPO has […]
More Stories
Analysts’ Weekly Ratings Updates for Altair Engineering (ALTR)
Several analysts have recently updated their ratings and price targets for Altair Engineering (NASDAQ: ALTR): 11/3/2024 – Altair Engineering was...
MeadowBrook Investment Advisors LLC Sells 414 Shares of Duke Energy Co. (NYSE:DUK)
MeadowBrook Investment Advisors LLC cut its stake in shares of Duke Energy Co. (NYSE:DUK – Free Report) by 21.7% during...
Tokio Marine Asset Management Co. Ltd. Raises Holdings in Mastercard Incorporated (NYSE:MA)
Tokio Marine Asset Management Co. Ltd. boosted its stake in Mastercard Incorporated (NYSE:MA – Free Report) by 2.6% in the...
BioRestorative Therapies (NASDAQ:BRTX) Issues Quarterly Earnings Results
BioRestorative Therapies (NASDAQ:BRTX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per...
Metis Global Partners LLC Buys 649 Shares of Union Pacific Co. (NYSE:UNP)
Metis Global Partners LLC increased its holdings in Union Pacific Co. (NYSE:UNP – Free Report) by 2.5% in the third...
Extendicare (TSE:EXE) Price Target Raised to C$10.50
Extendicare (TSE:EXE – Get Free Report) had its price target boosted by TD Securities from C$9.50 to C$10.50 in a...